SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
SEC Accession No. 0001193125-21-247747
Filing Date
2021-08-16
Accepted
2021-08-16 16:17:00
Documents
3
Group Members
ALAN FRAZIERALBERT CHAFHM LIFE SCIENCES VIII, L.L.C.FHM LIFE SCIENCES VIII, L.P.FHM VI, L.L.C.FHM VI, L.P.FHMLSP, L.L.C.FHMLSP, L.P.FRAZIER HEALTHCARE VI, L.P.FRAZIER LIFE SCIENCES VIII, L.P.JAMES BRUSHJAMES N. TOPPERNADER NAININATHAN EVERYPATRICK J. HERO

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13G d206571dsc13g.htm SC 13G 282875
2 EX-99.A d206571dex99a.htm EX-99.A 24450
3 EX-99.B d206571dex99b.htm EX-99.B 5475
  Complete submission text file 0001193125-21-247747.txt   314944
Mailing Address 2150 ? 885 WEST GEORGIA STREET VANCOUVER A1 V6C 3E8
Business Address 2150 ? 885 WEST GEORGIA STREET VANCOUVER A1 V6C 3E8 604-558-6536
Sierra Oncology, Inc. (Subject) CIK: 0001290149 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-89009 | Film No.: 211178452
SIC: 2834 Pharmaceutical Preparations

Mailing Address TWO UNION SQUARE, 601 UNION ST. SUITE 3200 SEATTLE WA 98101
Business Address TWO UNION SQUARE, 601 UNION ST. SUITE 3200 SEATTLE WA 98101 650-325-5156
Frazier Life Sciences Public Fund, L.P. (Filed by) CIK: 0001863769 (see all company filings)

IRS No.: 862999645 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G